These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||||
|
|
|
|||||||||||||
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|||||||||||||
|
|
|
|
|
|||||||||||
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
|||||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
x
|
Accelerated filer
|
☐ | ||||||||
|
Non-accelerated filer
|
☐ |
Smaller reporting company
|
|
||||||||
|
Emerging growth company
|
|
||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||
| (In millions, except share and per share data) | ||||||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Cost of sales |
|
|
|
|
||||||||||||||||||||||
| Gross profit |
|
|
|
|
||||||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
||||||||||||||||||||||
| Research and development costs |
|
|
|
|
||||||||||||||||||||||
| Loss due to misappropriation of assets, net |
|
|
|
|
||||||||||||||||||||||
| Other (income) expenses, net |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Income (loss) from operations |
(
|
|
|
|
||||||||||||||||||||||
| Interest and other financial expense, net |
|
|
|
|
||||||||||||||||||||||
| Reclassification of actuarial gain from AOCI |
|
(
|
|
(
|
||||||||||||||||||||||
| Income (loss) before earnings in affiliated companies and income taxes |
(
|
|
|
|
||||||||||||||||||||||
| Income tax expense (benefit) |
(
|
|
|
|
||||||||||||||||||||||
| Earnings in affiliated companies, net of tax |
|
|
|
|
||||||||||||||||||||||
| Net income (loss) | $ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Weighted-average shares outstanding (in thousands): | ||||||||||||||||||||||||||
| Basic |
|
|
|
|
||||||||||||||||||||||
| Diluted |
|
|
|
|
||||||||||||||||||||||
| Earnings (loss) per share: | ||||||||||||||||||||||||||
| Basic | $ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Diluted | $ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
1
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | |||||||||||||||||||||||
| (In millions) | ||||||||||||||||||||||||||
| Net income (loss) | $ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Other comprehensive income (loss), net of tax | ||||||||||||||||||||||||||
| Foreign currency translation adjustments |
|
|
(
|
(
|
||||||||||||||||||||||
| Net gains (losses) on derivatives |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Defined benefit plans, net |
|
(
|
|
(
|
||||||||||||||||||||||
| Other comprehensive income (loss) |
|
(
|
(
|
(
|
||||||||||||||||||||||
| Comprehensive income (loss) | $ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
2
| September 30, 2024 | December 31, 2023 | |||||||||||||||||||
| (In millions, except share data) | ||||||||||||||||||||
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||||||||
| Accounts receivable, net |
|
|
||||||||||||||||||
| Inventories, net |
|
|
||||||||||||||||||
| Income tax receivables |
|
|
||||||||||||||||||
| Prepaid expenses and other current assets |
|
|
||||||||||||||||||
| Total current assets |
|
|
||||||||||||||||||
| Property, plant and equipment, net |
|
|
||||||||||||||||||
| Right-of-use assets |
|
|
||||||||||||||||||
| Goodwill |
|
|
||||||||||||||||||
| Intangible assets, net |
|
|
||||||||||||||||||
| Investment in equity method affiliates |
|
|
||||||||||||||||||
| Deferred income tax assets |
|
|
||||||||||||||||||
| Other assets |
|
|
||||||||||||||||||
| Total non-current assets |
|
|
||||||||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||||||||
| Current portion of long-term debt and other financial liabilities |
|
|
||||||||||||||||||
| Accrued liabilities |
|
|
||||||||||||||||||
| Income taxes payable |
|
|
||||||||||||||||||
| Other current liabilities |
|
|
||||||||||||||||||
| Total current liabilities |
|
|
||||||||||||||||||
| Long-term debt, net |
|
|
||||||||||||||||||
| Employee benefit plan obligation |
|
|
||||||||||||||||||
| Deferred income tax liabilities |
|
|
||||||||||||||||||
| Other liabilities |
|
|
||||||||||||||||||
| Total non-current liabilities |
|
|
||||||||||||||||||
| Commitments and contingencies |
|
|
||||||||||||||||||
| Stockholders' equity | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
|
Authorized:
|
||||||||||||||||||||
|
Issued –
|
||||||||||||||||||||
|
Outstanding –
|
|
|
||||||||||||||||||
|
Treasury stock, at cost,
|
(
|
(
|
||||||||||||||||||
| Additional paid-in capital |
|
|
||||||||||||||||||
| Retained earnings |
|
|
||||||||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||||||||
| Total stockholders' equity |
|
|
||||||||||||||||||
| Total liabilities and stockholders' equity | $ |
|
$ |
|
||||||||||||||||
3
| Nine Months Ended September 30, | ||||||||||||||||||||
| 2024 | 2023 | |||||||||||||||||||
| (In millions) | ||||||||||||||||||||
| Cash flows from operating activities: | ||||||||||||||||||||
| Net income | $ |
|
$ |
|
||||||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||||||||||
| Depreciation of property, plant and equipment and amortization of intangible assets and right of use assets |
|
|
||||||||||||||||||
| Amortization of debt issuance costs |
|
|
||||||||||||||||||
| Share-based compensation |
|
|
||||||||||||||||||
| Deferred tax provision |
(
|
|
||||||||||||||||||
| Foreign currency transactions |
(
|
|
||||||||||||||||||
| Reclassification of actuarial gain from AOCI |
|
(
|
||||||||||||||||||
| Changes in operating assets and liabilities, net: | ||||||||||||||||||||
| Trade receivables |
(
|
|
||||||||||||||||||
| Inventories |
(
|
(
|
||||||||||||||||||
| Trade payables |
(
|
(
|
||||||||||||||||||
| Other provisions |
|
|
||||||||||||||||||
| Income tax liabilities |
(
|
|
||||||||||||||||||
| Other assets and liabilities, net |
(
|
(
|
||||||||||||||||||
| Net cash provided by operating activities |
|
|
||||||||||||||||||
| Cash flows from investing activities: | ||||||||||||||||||||
| Acquisition of property, plant and equipment |
(
|
(
|
||||||||||||||||||
| Net cash used in investing activities |
(
|
(
|
||||||||||||||||||
| Cash flows from financing activities: | ||||||||||||||||||||
| Proceeds from long-term debt borrowings |
|
|
||||||||||||||||||
| Repayments of long-term debt |
(
|
(
|
||||||||||||||||||
| Payments for debt issue costs |
(
|
(
|
||||||||||||||||||
| Cash inflows related to current financial liabilities |
|
|
||||||||||||||||||
| Cash outflows related to current financial liabilities |
(
|
(
|
||||||||||||||||||
| Dividends paid to shareholders |
(
|
(
|
||||||||||||||||||
| Repurchase of Common stock |
(
|
(
|
||||||||||||||||||
| Net cash provided by (used in) financing activities |
|
(
|
||||||||||||||||||
| Increase (decrease) in cash, cash equivalents and restricted cash |
|
(
|
||||||||||||||||||
| Cash, cash equivalents and restricted cash at the beginning of the period |
|
|
||||||||||||||||||
| Effect of exchange rate changes on cash |
|
(
|
||||||||||||||||||
| Cash, cash equivalents and restricted cash at the end of the period |
|
|
||||||||||||||||||
|
Less
restricted cash at the end of the period
|
|
|
||||||||||||||||||
| Cash and cash equivalents at the end of the period | $ |
|
$ |
|
||||||||||||||||
4
| Common stock | Treasury shares | Additional paid-in capital | Retained earnings | Accumulated other comprehensive loss | Total | |||||||||||||||||||||||||||||||||||||||||||||
| (In millions, except share and per share amounts) | Number | Amount | ||||||||||||||||||||||||||||||||||||||||||||||||
| Balance at January 1, 2024 |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss, net of tax | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Dividends |
$
|
per share | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||
| Repurchases of Common stock |
(
|
— |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Share based compensation | — | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock under equity compensation plans |
|
— |
|
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2024 |
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss, net of tax | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Dividends |
$
|
per share | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||
| Share based compensation | — | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock under equity compensation plans |
|
— |
|
(
|
— | — |
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2024 |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||
| Net loss | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive income, net of tax | — | — | — | — | — |
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Dividends |
$
|
per share | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||
| Repurchases of Common stock |
(
|
— |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Share based compensation | — | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2024 |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||
| Balance at January 1, 2023 |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss, net of tax | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Dividends |
$
|
per share | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||
| Repurchases of Common stock |
(
|
— |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Share based compensation | — | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock under equity compensation plans |
|
— |
|
(
|
— | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance at March 31, 2023 |
|
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss, net of tax | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Dividends |
$
|
per share | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||
| Repurchases of Common stock |
(
|
— |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Share based compensation | — | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||||||||||||||||
| Issuance of stock under equity compensation plans |
|
— |
|
(
|
— | — |
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance at June 30, 2023 |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||||||||||||||||
| Other comprehensive loss, net of tax | — | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Dividends |
$
|
per share | — | — | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||||||||||||||
| Repurchases of Common stock |
(
|
— |
(
|
— | — | — |
(
|
|||||||||||||||||||||||||||||||||||||||||||
| Share based compensation | — | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||||||||||||||||
| Balance at September 30, 2023 |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||||||||||||
5
| Table of Contents—Notes | ||||||||
| Note A. | ||||||||
| Note B. | ||||||||
| Note C. | ||||||||
| Note D. | ||||||||
| Note E. | ||||||||
| Note F. | ||||||||
| Note G. | ||||||||
| Note H. | ||||||||
| Note I. | ||||||||
| Note J. | ||||||||
| Note K. | ||||||||
6
| September 30, 2024 | December 31, 2023 | ||||||||||
| (In millions) | |||||||||||
| Accounts receivable | $ |
|
$ |
|
|||||||
| Expected credit losses |
(
|
(
|
|||||||||
| Accounts receivable, net | $ |
|
$ |
|
|||||||
7
| September 30, 2024 | December 31, 2023 | ||||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Raw materials, consumables and supplies, net | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Work in process |
|
|
|||||||||||||||||||||||||||||||||
| Finished goods, net |
|
|
|||||||||||||||||||||||||||||||||
| Inventories, net | $ |
|
$ |
|
|||||||||||||||||||||||||||||||
| September 30, 2024 | December 31, 2023 | ||||||||||
| (In millions) | |||||||||||
| Current | |||||||||||
| Current portion of Term-Loan | $ |
|
$ |
|
|||||||
| Deferred debt issuance costs - Term-Loan |
(
|
(
|
|||||||||
| Current portion of China Term-Loan |
|
|
|||||||||
| Other short-term debt and obligations |
|
|
|||||||||
| Current portion of long-term debt and other financial liabilities |
|
|
|||||||||
| Non-current | |||||||||||
| Term-Loan |
|
|
|||||||||
| Deferred debt issuance costs - Term-Loan |
(
|
(
|
|||||||||
| China Term-Loan |
|
|
|||||||||
| Long-term debt, net |
|
|
|||||||||
| Total | $ |
|
$ |
|
|||||||
8
| September 30, 2024 | December 31, 2023 | ||||||||||
| (In millions) | |||||||||||
| Revolving Credit Facility | $ |
|
$ |
|
|||||||
| Ancillary Credit Facilities | |||||||||||
| OEC GmbH outstanding borrowings |
|
|
|||||||||
| OEC LLC outstanding borrowings |
|
|
|||||||||
| OEC Huaibei outstanding borrowings |
|
|
|||||||||
|
Brazil Uncommitted Local Lines of Credit
(capacity $
|
|
|
|||||||||
|
Korea Working Capital Loan
(capacity $
|
|||||||||||
| Uncommitted |
|
|
|||||||||
| Committed |
|
|
|||||||||
| China Working Capital Loans |
|
|
|||||||||
| Repurchase Agreement |
|
|
|||||||||
| Total of Other Short-term Debt and Obligations | $ |
|
$ |
|
|||||||
| Supplemental information: | |||||||||||
| Total ancillary capacity - EUR | € |
|
€ |
|
|||||||
| Total ancillary capacity - U.S. Dollars | $ |
|
$ |
|
|||||||
9
| September 30, 2024 | December 31, 2023 | Balance Sheet Classification | |||||||||||||||||||||||||||
| Notional Amount | Fair Value | Notional Amount | Fair Value | ||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||
| Derivatives designated as hedges: | |||||||||||||||||||||||||||||
| Cross currency swaps | $ |
|
$ |
|
$ |
|
$ |
|
Other financial assets (non-current) | ||||||||||||||||||||
| Interest rate swaps |
|
|
|
|
Other financial assets (non-current) | ||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| September 30, 2024 | December 31, 2023 | ||||||||||||||||||||||
| Notional Amount | Fair Value | Notional Amount | Fair Value | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Non-derivatives: | |||||||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||
| Term-Loan | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| China Term-Loan |
|
|
|
|
|||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
10
| Effect of Financial Instruments | |||||||||||||||||||||||||||||||||||
| Three Months Ended Sep 30, | |||||||||||||||||||||||||||||||||||
| Gain (Loss) Recognized in AOCI | Gain (Loss) Reclassified from AOCI to Income | Income Statement Classification | |||||||||||||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Derivatives designated as hedges: | |||||||||||||||||||||||||||||||||||
| Cross currency swaps | $ |
(
|
$ |
|
$ |
(
|
$ |
|
Interest and other financial expense, net | ||||||||||||||||||||||||||
| Interest rate swaps |
|
(
|
(
|
|
Interest and other financial expense, net | ||||||||||||||||||||||||||||||
| Total | $ |
(
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Effect of Financial Instruments | |||||||||||||||||||||||||||||||||||
| Nine Months Ended September 30, | |||||||||||||||||||||||||||||||||||
| Gain (Loss) Recognized in AOCI | Gain (Loss) Reclassified from AOCI to Income | Income Statement Classification | |||||||||||||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||||||||||||||
| Derivatives designated as hedges: | |||||||||||||||||||||||||||||||||||
| Cross currency swaps | $ |
(
|
$ |
|
$ |
|
$ |
|
Interest and other financial expense, net | ||||||||||||||||||||||||||
| Interest rate swaps |
(
|
(
|
(
|
|
Interest and other financial expense, net | ||||||||||||||||||||||||||||||
| Total | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Interest cost |
|
|
|
|
|||||||||||||||||||
| Amortization of actuarial (gain) |
|
(
|
|
(
|
|||||||||||||||||||
| Net periodic pension cost | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||
11
| Currency Translation Adjustments | Hedging Activities Adjustments | Pension and Other Postretirement Benefit Liability Adjustment | Total | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Balance at January 1, 2024 | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Other comprehensive income (loss) before reclassifications |
(
|
(
|
|
(
|
|||||||||||||||||||
| Income tax effects before reclassifications |
(
|
|
(
|
(
|
|||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
|
|||||||||||||||||||
| Income tax effects on reclassifications |
|
(
|
|
(
|
|||||||||||||||||||
| Currency translation AOCI |
|
(
|
|
(
|
|||||||||||||||||||
| Balance at March 31, 2024 |
(
|
|
(
|
(
|
|||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
(
|
(
|
|
(
|
|||||||||||||||||||
| Income tax effects before reclassifications |
(
|
|
|
|
|||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
|
|||||||||||||||||||
| Income tax effects on reclassifications |
|
(
|
|
(
|
|||||||||||||||||||
| Currency translation AOCI |
|
(
|
|
(
|
|||||||||||||||||||
| Balance at June 30, 2024 | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Other comprehensive income (loss) before reclassifications |
|
(
|
|
(
|
|||||||||||||||||||
| Income tax effects before reclassifications |
|
|
|
|
|||||||||||||||||||
| Amounts reclassified from AOCI |
|
(
|
|
(
|
|||||||||||||||||||
| Income tax effects on reclassifications |
|
|
|
|
|||||||||||||||||||
| Currency translation AOCI |
|
|
|
|
|||||||||||||||||||
| Balance at September 30, 2024 | $ |
(
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
12
| Currency Translation Adjustments | Hedging Activities Adjustments | Pension and Other Postretirement Benefit Liability Adjustment | Total | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Balance at January 1, 2023 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
| Other comprehensive income (loss) before reclassifications |
(
|
(
|
|
(
|
|||||||||||||||||||
| Income tax effects before reclassifications |
|
|
|
|
|||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
(
|
(
|
|||||||||||||||||||
| Income tax effects on reclassifications |
|
(
|
|
|
|||||||||||||||||||
| Currency translation AOCI |
|
|
|
|
|||||||||||||||||||
| Balance at March 31, 2023 |
(
|
|
|
(
|
|||||||||||||||||||
| Other comprehensive income (loss) before reclassifications |
(
|
(
|
|
(
|
|||||||||||||||||||
| Income tax effects before reclassifications |
(
|
|
|
|
|||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
(
|
(
|
|||||||||||||||||||
| Income tax effects on reclassifications |
|
(
|
|
|
|||||||||||||||||||
| Currency translation AOCI |
|
(
|
|
(
|
|||||||||||||||||||
| Balance at June 30, 2023 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
| Other comprehensive income (loss) before reclassifications |
|
|
|
|
|||||||||||||||||||
| Income tax effects before reclassifications |
(
|
(
|
|
(
|
|||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
(
|
(
|
|||||||||||||||||||
| Income tax effects on reclassifications |
|
(
|
|
|
|||||||||||||||||||
| Currency translation AOCI |
|
(
|
(
|
(
|
|||||||||||||||||||
| Balance at September 30, 2023 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
|
(In millions, except share and per share data)
|
|||||||||||||||||||||||
| Net income (loss) attributable to ordinary equity holders | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Weighted average number of Common stock (in thousands) |
|
|
|
|
|||||||||||||||||||
| Basic Earnings (loss) per share | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Dilutive effect of share based payments (in thousands) |
|
|
|
|
|||||||||||||||||||
| Weighted average number of diluted Common stock (in thousands) |
|
|
|
|
|||||||||||||||||||
| Diluted Earnings (loss) per share | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
13
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| Effective income tax rates |
|
% |
|
% |
|
% |
|
% | |||||||||||||||
14
| Rubber | Specialty | Corporate | Total | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| 2024 | |||||||||||||||||||||||
| Net sales from external customers | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization of intangible assets, right of use assets, and property, plant and equipment |
|
|
|
|
|||||||||||||||||||
| Equity in earnings of affiliated companies, net of tax |
|
|
|
|
|||||||||||||||||||
| Interest and other financial expense, net |
(
|
(
|
|||||||||||||||||||||
| Adjusted EBITDA |
|
|
|
|
|||||||||||||||||||
| 2023 | |||||||||||||||||||||||
| Net sales from external customers | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization of intangible assets, right of use assets, and property, plant and equipment |
|
|
|
|
|||||||||||||||||||
| Equity in earnings of affiliated companies, net of tax |
|
|
|
|
|||||||||||||||||||
| Interest and other financial expense, net |
(
|
(
|
|||||||||||||||||||||
| Reclassification of actuarial gain from AOCI |
|
|
|||||||||||||||||||||
| Adjusted EBITDA |
|
|
|
|
|||||||||||||||||||
15
| Rubber | Specialty | Corporate | Total | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| 2024 | |||||||||||||||||||||||
| Net sales from external customers | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization of intangible assets, right of use assets, and property, plant and equipment |
|
|
|
|
|||||||||||||||||||
| Equity in earnings of affiliated companies, net of tax |
|
|
|
|
|||||||||||||||||||
| Interest and other financial expense, net |
(
|
(
|
|||||||||||||||||||||
| Adjusted EBITDA |
|
|
|
|
|||||||||||||||||||
| 2023 | |||||||||||||||||||||||
| Net sales from external customers | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Depreciation and amortization of intangible assets, right of use assets, and property, plant and equipment |
|
|
|
|
|||||||||||||||||||
| Excluding equity in earnings of affiliated companies, net of tax |
|
|
|
|
|||||||||||||||||||
| Interest and other financial expense, net |
(
|
(
|
|||||||||||||||||||||
| Reclassification of actuarial losses from AOCI |
|
|
|||||||||||||||||||||
| Adjusted EBITDA |
|
|
|
|
|||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Income (loss) before earnings in affiliated companies and income taxes | $ |
(
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Corporate charges |
|
|
|
|
|||||||||||||||||||
| Depreciation and amortization of intangible assets, right of use assets, and property, plant and equipment |
|
|
|
|
|||||||||||||||||||
| Equity in earnings of affiliated companies, net of tax |
|
|
|
|
|||||||||||||||||||
| Interest and other financial expense, net |
|
|
|
|
|||||||||||||||||||
| Reclassification of actuarial gain from AOCI |
|
(
|
|
(
|
|||||||||||||||||||
| Adjusted EBITDA | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Loss due to misappropriation of assets, net: | |||||||||||||||||||||||
| Misappropriation of assets, net | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Professional fees related to misappropriation of assets | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Long term incentive plan | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other non-operating |
(
|
|
(
|
(
|
|||||||||||||||||||
| Corporate Charges | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
16
17
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||
| 2024 | 2023 | Delta | 2024 | 2023 | Delta | ||||||||||||||||||||||||||||||||||||||||||
| (In millions, except volume) | % | (In millions, except volume) | % | ||||||||||||||||||||||||||||||||||||||||||||
| Volume (in kmt) | 225.2 | 245.2 | (20.0) | (8.2) | 706.7 | 706.0 | 0.7 | 0.1 | |||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 463.4 | $ | 466.2 | $ | (2.8) | (0.6) | $ | 1,443.3 | $ | 1,425.7 | $ | 17.6 | 1.2 | |||||||||||||||||||||||||||||||||
| Cost of sales | 355.9 | 356.0 | (0.1) | — | 1,103.8 | 1,062.0 | 41.8 | 3.9 | |||||||||||||||||||||||||||||||||||||||
| Gross profit | 107.5 | 110.2 | (2.7) | (2.5) | 339.5 | 363.7 | (24.2) | (6.7) | |||||||||||||||||||||||||||||||||||||||
| Selling, general and administrative expenses | 57.9 | 55.6 | 2.3 | 4.1 | 179.7 | 168.3 | 11.4 | 6.8 | |||||||||||||||||||||||||||||||||||||||
| Research and development costs | 7.0 | 6.2 | 0.8 | 12.9 | 20.1 | 18.3 | 1.8 | 9.8 | |||||||||||||||||||||||||||||||||||||||
| Loss due to misappropriation of assets, net | 60.7 | — | 60.7 | N/A | 60.7 | — | 60.7 | N/A | |||||||||||||||||||||||||||||||||||||||
| Other income, net | (2.8) | 2.7 | (5.5) | (203.7) | (0.1) | (1.0) | 0.9 | (90.0) | |||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | (15.3) | 45.7 | (61.0) | (133.5) | 79.1 | 178.1 | (99.0) | (55.6) | |||||||||||||||||||||||||||||||||||||||
| Interest and other financial expense, net | 15.9 | 12.9 | 3.0 | 23.3 | 40.8 | 41.6 | (0.8) | (1.9) | |||||||||||||||||||||||||||||||||||||||
| Reclassification of actuarial gain from AOCI | — | (2.2) | 2.2 | (100.0) | — | (6.7) | 6.7 | (100.0) | |||||||||||||||||||||||||||||||||||||||
| Income (loss) before earnings in affiliated companies and income taxes | (31.2) | 35.0 | (66.2) | (189.1) | 38.3 | 143.2 | (104.9) | (73.3) | |||||||||||||||||||||||||||||||||||||||
| Income tax expense (benefit) | (10.8) | 8.9 | (19.7) | (221.3) | 11.8 | 45.0 | (33.2) | (73.8) | |||||||||||||||||||||||||||||||||||||||
| Earnings in affiliated companies, net of tax | 0.2 | 0.1 | 0.1 | 100.0 | 0.5 | 0.4 | 0.1 | 25.0 | |||||||||||||||||||||||||||||||||||||||
| Net income (loss) | (20.2) | 26.2 | (46.4) | (177.1) | 27.0 | 98.6 | (71.6) | (72.6) | |||||||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss), net of tax | |||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | 3.3 | 0.3 | 3.0 | 1,000.0 | (11.4) | (12.2) | 0.8 | (6.6) | |||||||||||||||||||||||||||||||||||||||
| Net gains (losses) on derivatives | (3.2) | 0.9 | (4.1) | (455.6) | (4.9) | (1.3) | (3.6) | 276.9 | |||||||||||||||||||||||||||||||||||||||
| Defined benefit plans, net | — | (1.7) | 1.7 | (100.0) | 0.2 | (4.6) | 4.8 | (104.3) | |||||||||||||||||||||||||||||||||||||||
| Total other comprehensive (loss) income, net of tax | 0.1 | (0.5) | 0.6 | (120.0) | (16.1) | (18.1) | 2.0 | (11.0) | |||||||||||||||||||||||||||||||||||||||
| Comprehensive income (loss) | $ | (20.1) | $ | 25.7 | $ | (45.8) | (178.2) | $ | 10.9 | $ | 80.5 | $ | (69.6) | (86.5) | |||||||||||||||||||||||||||||||||
18
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||
| 2024 | 2023 | Delta | 2024 | 2023 | Delta | ||||||||||||||||||||||||||||||||||||||||||
| (In millions) | % | (In millions) | % | ||||||||||||||||||||||||||||||||||||||||||||
| Net income (loss) | $ | (20.2) | $ | 26.2 | $ | (46.4) | (177.1) | $ | 27.0 | $ | 98.6 | $ | (71.6) | (72.6) | |||||||||||||||||||||||||||||||||
| Add back Income tax (benefit) expense | (10.8) | 8.9 | (19.7) | (221.3) | 11.8 | 45.0 | (33.2) | (73.8) | |||||||||||||||||||||||||||||||||||||||
| Add back Equity in earnings of affiliated companies, net of tax | (0.2) | (0.1) | (0.1) | 100.0 | (0.5) | (0.4) | (0.1) | 25.0 | |||||||||||||||||||||||||||||||||||||||
| Income (loss) before earnings in affiliated companies and income taxes | (31.2) | 35.0 | (66.2) | (189.1) | 38.3 | 143.2 | (104.9) | (73.3) | |||||||||||||||||||||||||||||||||||||||
| Add back Interest and other financial expense, net | 15.9 | 12.9 | 3.0 | 23.3 | 40.8 | 41.6 | (0.8) | (1.9) | |||||||||||||||||||||||||||||||||||||||
| Add back Reclassification of actuarial gain from AOCI | — | (2.2) | 2.2 | (100.0) | — | (6.7) | 6.7 | (100.0) | |||||||||||||||||||||||||||||||||||||||
| Income (loss) from operations | (15.3) | 45.7 | (61.0) | (133.5) | 79.1 | 178.1 | (99.0) | (55.6) | |||||||||||||||||||||||||||||||||||||||
| Add back Depreciation of property, plant and equipment and amortization of intangible assets and right of use assets | 30.8 | 27.9 | 2.9 | 10.4 | 90.0 | 80.8 | 9.2 | 11.4 | |||||||||||||||||||||||||||||||||||||||
| EBITDA | 15.5 | 73.6 | (58.1) | (78.9) | 169.1 | 258.9 | (89.8) | (34.7) | |||||||||||||||||||||||||||||||||||||||
| Equity in earnings of affiliated companies, net of tax | 0.2 | 0.1 | 0.1 | 100.0 | 0.5 | 0.4 | 0.1 | 25.0 | |||||||||||||||||||||||||||||||||||||||
| Loss due to misappropriation of assets, net: | |||||||||||||||||||||||||||||||||||||||||||||||
| Misappropriation of assets, net | 59.2 | — | 59.2 | — | 59.2 | — | 59.2 | — | |||||||||||||||||||||||||||||||||||||||
| Professional fees related to misappropriation of assets | 1.5 | — | 1.5 | — | 1.5 | — | 1.5 | — | |||||||||||||||||||||||||||||||||||||||
| Long term incentive plan | 4.8 | 3.6 | 1.2 | 33.3 | 11.3 | 8.3 | 3.0 | 36.1 | |||||||||||||||||||||||||||||||||||||||
| Other adjustments | (1.1) | — | (1.1) | — | (1.1) | (1.9) | 0.8 | (42.1) | |||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 80.1 | $ | 77.3 | $ | 2.8 | 3.6 | $ | 240.5 | $ | 265.7 | $ | (25.2) | (9.5) | |||||||||||||||||||||||||||||||||
|
Adjusted EBITDA Specialty Carbon Black
|
$ | 27.2 | $ | 26.1 | $ | 1.1 | 4.2 | $ | 83.1 | $ | 93.3 | $ | (10.2) | (10.9) | |||||||||||||||||||||||||||||||||
|
Adjusted EBITDA Rubber Carbon Black
|
$ | 52.9 | $ | 51.2 | $ | 1.7 | 3.3 | $ | 157.4 | $ | 172.4 | $ | (15.0) | (8.7) | |||||||||||||||||||||||||||||||||
19
20
21
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||||||||||||||
| 2024 | 2023 | Delta | 2024 | 2023 | Delta | ||||||||||||||||||||||||||||||||||||||||||
|
|
% | (In millions, except volume) | % | ||||||||||||||||||||||||||||||||||||||||||||
| Specialty Carbon Black | |||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 162.5 | $ | 150.4 | $ | 12.1 | 8.0 | $ | 498.9 | $ | 461.9 | $ | 37.0 | 8.0 | |||||||||||||||||||||||||||||||||
| Cost of sales | 125.9 | 111.8 | 14.1 | 12.6 | 381.1 | 328.6 | 52.5 | 16.0 | |||||||||||||||||||||||||||||||||||||||
| Gross profit | $ | 36.6 | $ | 38.6 | $ | (2.0) | (5.2) | $ | 117.8 | $ | 133.3 | $ | (15.5) | (11.6) | |||||||||||||||||||||||||||||||||
| Volume (kmt) | 59.7 | 59.9 | (0.2) | (0.3) | 185.9 | 166.5 | 19.4 | 11.7 | |||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 27.2 | $ | 26.1 | $ | 1.1 | 4.2 | $ | 83.1 | $ | 93.3 | $ | (10.2) | (10.9) | |||||||||||||||||||||||||||||||||
| Rubber Carbon Black | |||||||||||||||||||||||||||||||||||||||||||||||
| Net sales | $ | 300.9 | $ | 315.8 | $ | (14.9) | (4.7) | $ | 944.4 | $ | 963.8 | $ | (19.4) | (2.0) | |||||||||||||||||||||||||||||||||
| Cost of sales | 230.0 | 244.2 | (14.2) | (5.8) | 722.7 | 733.4 | (10.7) | (1.5) | |||||||||||||||||||||||||||||||||||||||
| Gross profit | $ | 70.9 | $ | 71.6 | $ | (0.7) | (1.0) | $ | 221.7 | $ | 230.4 | $ | (8.7) | (3.8) | |||||||||||||||||||||||||||||||||
| Volume (kmt) | 165.5 | 185.3 | (19.8) | (10.7) | 520.8 | 539.5 | (18.7) | (3.5) | |||||||||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 52.9 | $ | 51.2 | $ | 1.7 | 3.3 | $ | 157.4 | $ | 172.4 | $ | (15.0) | (8.7) | |||||||||||||||||||||||||||||||||
22
| Nine Months Ended September 30, | |||||||||||
| 2024 | 2023 | ||||||||||
| (In millions, except volume) | |||||||||||
| Net cash provided by operating activities | $ | 30.8 | $ | 273.7 | |||||||
| Net cash used in investing activities | (135.7) | (111.0) | |||||||||
| Net cash provided by (used in) financing activities | 119.3 | (164.9) | |||||||||
23
| September 30, 2024 | December 31, 2023 | |||||||||||||||||||
| (In millions, except volume) | ||||||||||||||||||||
| Accounts receivable, net | $ | 267.9 | $ | 241.0 | ||||||||||||||||
| Inventories, net | 306.7 | 287.1 | ||||||||||||||||||
| Accounts payable | (174.7) | (183.7) | ||||||||||||||||||
| Net working capital | $ | 399.9 | $ | 344.4 | ||||||||||||||||
24
25
26
27
| Period | Total number of shares of Common stock purchased | Average price paid per stock | Total number of shares of Common stock purchased as part of publicly announced plans | Maximum number of shares of Common stock yet be purchased as part of publicly announced plans | ||||||||||||||||||||||
| 6.9 million of Common Stock Repurchase Program | ||||||||||||||||||||||||||
|
July 1 — 31, 2024
|
— | $ | — | — | 6,021,277 | |||||||||||||||||||||
|
August 1 — 31, 2024
|
403,552 | 17.81 | 403,552 | 5,617,725 | ||||||||||||||||||||||
|
September 1 — 30, 2024
|
232,850 | 16.90 | 232,850 | 5,384,875 | ||||||||||||||||||||||
|
Repurchased in 2024 third quarter
|
636,402 | 636,402 | 5,384,875 | |||||||||||||||||||||||
28
| Exhibit Number | Description | |||||||
| 31.1 | * | |||||||
| 31.2 | * | |||||||
| 32.1 | ** | |||||||
| 32.2 | ** | |||||||
| 101.INS | Inline XBRL Instance Document. | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema. | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase. | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase. | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase. | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Document. | |||||||
| 104.0 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | |||||||
| * | Filed herewith | |||||||
| ** | Furnished herewith | |||||||
| † | Management compensatory arrangement | |||||||
|
ORION S.A.
|
||||||||
| November 7, 2024 | By | /s/ Jeffrey Glajch | ||||||
| Name: Jeffrey Glajch | ||||||||
| Title: Chief Financial Officer | ||||||||
30
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|